Moving Past Mysticism in Psychedelic Science

This commentary (2021) examines the role of mystical frameworks within psychedelic research and identifies the problem of putting subjective experiences into a black box by labeling them as 'ineffable' and inaccessible to scientific inquiry. The authors recommend a theoretic shift away from supernatural or nonempirical belief systems in favor of a secular framework that aims to measure those experiences more objectively.

Authors

  • Sanders, J. W.

Published

ACS Pharmacology and Translational Science
meta Study

Abstract

The mysticism framework is used to describe psychedelic experiences and explain the effects of psychedelic therapies. We discuss risks and difficulties stemming from the scientific use of a framework associated with supernatural or nonempirical belief systems and encourage researchers to mitigate these risks with a demystified model of the psychedelic state.

Available with Blossom Pro

Research Summary of 'Moving Past Mysticism in Psychedelic Science'

Introduction

Earlier literature linking psychedelic experiences with mysticism has shaped much contemporary psychedelic research and clinical practice. Sanders and colleagues trace this lineage to W. T. Stace's mid‑20th century concept of a distinctive "mystical consciousness", characterised by features such as unity, timelessness, sacredness, paradoxicality and ineffability. Early researchers operationalised Stace's criteria into psychometric instruments—most notably the Mystical Experience Questionnaire, Hood's Mysticism Scale and certain dimensions of the Altered States of Consciousness Questionnaire—which have shown internal reliability and some predictive validity for therapeutic outcomes. Against this background, the authors identify a worrying gap: persistent reliance on mysticism imports theological or supernatural connotations into scientific discourse, risks creating a ‘‘black box’’ mentality that treats aspects of the psychedelic state as beyond empirical inquiry, and may bias participant responses by priming mystical interpretations. The paper sets out to argue that psychedelic science should replace mysticism as a guiding framework with demystified, secular, empirically grounded models that better link subjective reports to psychobiological mechanisms and avoid problematic public misinterpretation.

Expert Research Summaries

Go Pro to access AI-powered section-by-section summaries, editorial takes, and the full research toolkit.

Full Text PDF

Full Paper PDF

Create a free account to open full-text PDFs.

Study Details

  • Study Type
    meta
  • Journal
  • APA Citation

    Sanders, J. W., & Zijlmans, J. (2021). Moving Past Mysticism in Psychedelic Science. ACS Pharmacology & Translational Science, 4(3), 1253-1255. https://doi.org/10.1021/acsptsci.1c00097

References (4)

Papers cited by this study that are also in Blossom

Consciousness, Religion, and Gurus: Pitfalls of Psychedelic Medicine

Johnson, M. W. · ACS Pharmacology and Translational Science (2020)

REBUS and the Anarchic Brain: Toward a Unified Model of the Brain Action of Psychedelics

Carhart-Harris, R. L., Friston, K. J. · Pharmacological Reviews (2019)

Psychometric evaluation of the altered states of consciousness rating scale (OAV)

Studerus, E., Gamma, A., Vollenweider, F. X. · PLOS ONE (2010)

Quality of acute psychedelic experience predicts therapeutic efficacy of psilocybin for treatment-resistant depression

Roseman, L., Nutt, D. J., Carhart-Harris, R. L. · Frontiers in Pharmacology (2018)

Cited By (16)

Papers in Blossom that reference this study

Mixed-methods analysis on psychedelic-augmented meditation experiences from a randomized controlled mindfulness retreat

Schlomberg, J. T. T., Meling, D., Grylka, R. et al. · Scientific Reports (2026)

Insights on Psychedelics: A Systematic Review of Therapeutic Effects

Kugel, J., Laukkonen, R., Yaden, D. B. et al. · Neuroscience and Biobehavioral Reviews (2025)

DMT micro-phenomenology

Sanders, J. W., Milliere, R., Daily, Z. G. et al. · Preprints (2024)

Naturalistic psychedelic therapy: The role of relaxation and subjective drug effects in antidepressant response

Calder, A. E., Rausch, B., Liechti, M. E. et al. · Journal of Psychopharmacology (2024)

Naturalism and the hard problem of mysticism in psychedelic science

Jylkkä, J. · Frontiers in Psychology (2024)

N, N-Dimethyltryptamine (DMT)-Occasioned Familiarity and the Sense of Familiarity Questionnaire (SOF-Q)

Lawrence, D. W., Timmermann, C. · Journal of Psychoactive Drugs (2023)

Transpersonal Ecodelia: Surveying Psychedelically Induced Biophilia

Luke, D., Gandy, S., Irvine, A. et al. · Psychoactives (2023)

17 cited
On the need for metaphysics in psychedelic therapy and research

Sjöstedt-Hughes, P. · Frontiers in Psychology (2023)

Lower-dose psycholytic therapy - A neglected approach

Passie, T., Guss, J., Kraehenmann, R. · Frontiers in Psychiatry (2022)

Show all 16 papers
Psychedelics, Mystical Experience, and Therapeutic Efficacy: A Systematic Review

Knight, G., Rucker, J., Cleare, A. J. et al. · Frontiers in Psychiatry (2022)

Predictors and potentiators of psychedelic-occasioned mystical experiences

Gandy, S. · Journal of Psychedelic Studies (2022)

Psilocybin-Induced Mystical-Type Experiences are Related to Persisting Positive Effects: A Quantitative and Qualitative Report

McCulloch, D. E-W., Madsen, M. K., Jensen, P. S. et al. · Frontiers in Pharmacology (2022)

79 cited
Working with Weirdness: A Response to “Moving Past Mysticism in Psychedelic Science”

Breeksema, J. J., van Elk, M. · ACS Pharmacology and Translational Science (2021)

Your Personal Research Library

Go Pro to save papers, add notes, rate studies, and organize your research into custom shelves.

Moving Past Mysticism in Psychedelic Science — Research Summary & Context | Blossom